Abstract Background Depressive and anxiety disorders are significantly more common in women than in men [1]. Despite higher prevalence, there is paucity of published evidence on the evaluation of efficacy and safety of drugs used for these conditions in women [2]. Various guidelines recommend inclusion of women and min...
C. Correll, A. Fagiolini, M. P. Mariano et al.· International Journal of Neu...· 0 citations
ABSTRACT Introduction Acute suicidal ideation in major depressive disorder (MDD) is a psychiatric emergency requiring rapid risk assessment, containment, and treatment. Conventional monoaminergic antidepressants have delayed onset, leaving an interval during which severe depressive distress persists. Intranasal esketam...
M. Pinzi, A. Cuomo, M. B. Rescalli et al.· Expert Review of Neurotherap...· 0 citations
Abstract Background Clinical studies have shown that ketamine and classic psychedelics can produce robust and rapid antidepressant effects after a single or a few administrations. However, the neurobiological mechanisms driving these long-lasting changes remain unclear. A leading framework proposes that both drug class...
C. Agnorelli, J. Peill, D. Kurtin et al.· International Journal of Neu...· 0 citations
Highlights What are the main findings? ADHD changes across development, shifting from overt hyperactivity and impulsivity in childhood toward inner restlessness, executive dysfunction, disorganization, and impaired self-regulation in adulthood. The recent increase in adult ADHD diagnoses is compatible with several over...
A. Cuomo, M. Pinzi, A. Fagiolini· Brain Science· 0 citations
This post-hoc analysis of clinical studies of alprazolam demonstrated the effect of its short-term use in alleviating autonomic hyperactivity, tension, and intellectual issues and may offer a neurobiological basis for GAD.
S. Shirol, S. Awasthi, A. Fagiolini et al.· International Journal of Neu...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
